A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BAS / Barnes Akathisia Scale

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BAS  (>> Co-occurring Abbreviation)
Long Form:   Barnes Akathisia Scale
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial. EPS, LLD, SAS
2016 Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial. AIMS, ASEX, CAI, ER, GAF, PANSS, SANS, SARS, UKU
2015 Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset. ---
2014 The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial. AIMS, BACS-J, CGI-S, DIEPSS, EPS, PAL, PANSS
2013 Aripiprazole alone or in combination for acute mania. AIMS, CI, MD, SAS, WHO, YMRS
2011 Delayed-onset akathisia due to amisulpride. DSM-IV
2010 Structured relaxation in the treatment of akathisia: case series. ---
2008 Olanzapine versus droperidol for the treatment of primary headache in the emergency department. ED, IM, VAS, VRS
2008 Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia. AIMS, BPRS, EPS, MD, SANS/SAPS, TDRS
10  2007 Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. CGI, ESRS, PANSS, UKU
11  2007 Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial. CGI-S, EC, FDA, PANSS, SAS
12  2007 Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. EPS, IBZM, SAS
13  2006 Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. AIA, CI
14  2006 Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment. AIMS, EPS, MDs, TD, TDRS
15  2005 The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study. APDs, NIA
16  2004 A pilot study of barriers to medication adherence in schizophrenia. OR, PANSS, SGP
17  2004 An open-label trial of olanzapine for corticosteroid-induced mood symptoms. AIMS, BPRS, HRSD, SAS, YMRS
18  2004 Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study. BPRS, CGI, GABA, NIA
19  2003 Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects. SAS
20  2003 An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine. EPS
21  2003 Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics. CDSS, CGI, EPS, PANSS, SAS, SPECTRUM
22  2003 Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study. NIA
23  2003 Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial. AIMS, HAL, LOCF, MMRM, OLZ, PPCT, SAS
24  2000 Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia. NIA
25  2000 Sertindole is associated with a low level of extrapyramidal symptoms in schizophrenic patients: Results of a phase III trial. AIMS, EPS, SAS
26  2000 The Schedule for the Assessment of Drug-Induced Movement Disorders (SADIMoD): test-retest reliability and concurrent validity. AIMS, SADIMoD
27  1997 Interrater reliability issues in multicenter trials, Part II: Statistical procedures used in Department of Veterans Affairs Cooperative Study #394. AIMS, BPRS, CS, GAF, ICCs, IRR, TD, VA
28  1993 Reliability and applicability of movement disorder rating scales in the elderly. AIMS, SEPSE